Encompass Health Corporation
EHC
$107.93
-$1.02-0.94%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 146.10M | 126.50M | 142.10M | 151.50M | 120.90M |
| Total Depreciation and Amortization | 86.40M | 82.40M | 79.90M | 79.20M | 78.00M |
| Total Amortization of Deferred Charges | 9.60M | -- | -- | -- | 9.70M |
| Total Other Non-Cash Items | 90.00M | 60.10M | 52.10M | 65.40M | 67.40M |
| Change in Net Operating Assets | 13.90M | 1.80M | -3.90M | -7.50M | 2.80M |
| Cash from Operations | 346.00M | 270.80M | 270.20M | 288.60M | 278.80M |
| Capital Expenditure | -229.30M | -187.10M | -156.90M | -163.10M | -198.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.10M | -14.20M | -8.50M | 4.60M | -5.00M |
| Cash from Investing | -239.40M | -201.30M | -165.40M | -158.50M | -203.70M |
| Total Debt Issued | 70.00M | 80.00M | 0.00 | 60.00M | 30.00M |
| Total Debt Repaid | -28.10M | -108.60M | -22.30M | -80.00M | -117.40M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -76.40M | -24.90M | -24.80M | -51.90M | -7.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -19.00M | -17.00M | -17.10M | -18.00M | -17.00M |
| Other Financing Activities | -43.90M | -42.70M | -26.00M | -40.50M | -39.00M |
| Cash from Financing | -97.40M | -113.20M | -90.20M | -130.40M | -150.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.20M | -43.70M | 14.60M | -300.00K | -75.80M |